Bioretec announced today that it plans to move forward with its next phase of commercialization for its RemeOs products in the U.S. The Finland-based company inked a new sales and distribution agreement with Tri-State Biologics (TSB). New Jersey-based TSB distributes medical and surgical products, with 18 sales representatives aiding in medical device distribution. This agreement […]
Bioretec
Bioretec to increase production capacity for bioresorbable implants
Bioretec announced today that it acquired a new CNC machining center to increase the production capacity of its RemeOs products. Tampere, Finland-based Bioretec said its acquisition is optimized for the production of magnesium-based implants. This especially includes the first product from the RemeOs family, the RemeOs screw. Bioretec’s RemeOs screw received FDA approval in March. […]
FDA approves bioresorbable metal implant from Bioretec
Bioretec announced today that it received FDA marketing authorization for its RemeOs trauma screw, a bioresorbable metal implant. Tampere, Finland-based Bioretec says the screw is the first and only bioresorbable metal implant approved by the FDA. The product’s range and indication align with a clinical trial conducted in the ankle, according to a news release. […]
Study demonstrates benefits of Bioretec’s bioresorbable pediatric wrist implant
Bioretec announced today that published clinical trial results support the use of its bioresorbable ActivaPin implant. Helsinki-based Bioretec designed the ActivaPin implants for pediatric patients to treat severely displaced distal radius and forearm fractures. According to a news release, the results from the retrospective, multicenter study demonstrated that patients treated with ActivaPin has a significantly […]
